Drug Profile
MTC-Melphalan
Latest Information Update: 03 Dec 2021
Price :
$50
*
At a glance
- Originator FeRx
- Class Antineoplastics; Aromatic amino acids; Myeloablative agonists; Nitrogen mustard compounds; Small molecules
- Mechanism of Action Alkylating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Solid tumours
Most Recent Events
- 13 Jul 2004 Preclinical trials in Solid tumours in USA (unspecified route)